PL357385A1 - Nowe pochodne pirymidyno-2,4,6-trionu, sposoby ich wytwarzania i środki farmaceutyczne zawierające te związki - Google Patents

Nowe pochodne pirymidyno-2,4,6-trionu, sposoby ich wytwarzania i środki farmaceutyczne zawierające te związki

Info

Publication number: PL357385A1
Authority: PL; Poland
Prior art keywords: compounds; processes; production; pharmaceutical agents; agents containing
Prior art date: 1999-10-01

Application number

PL00357385A

Other languages

English (en)

Other versions

PL202680B1 (pl

Inventor

Frank Grams

Hans-Willi Krell

Herbert Leinert

Ernesto Menta

Gerd Zimmermann

Original Assignee

F.Hoffmann-La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-01

Filing date

2000-09-29

Publication date

2004-07-26

2000-09-29 Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag

2004-07-26 Publication of PL357385A1 publication Critical patent/PL357385A1/pl

2009-07-31 Publication of PL202680B1 publication Critical patent/PL202680B1/pl

Links

HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical class O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000008177 pharmaceutical agent Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL357385A 1999-10-01 2000-09-29 Nowe pochodne pirymidyno-2,4,6-trionu, środek farmaceutyczny i zastosowanie tych pochodnych PL202680B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99119506		1999-10-01
PCT/EP2000/009535 WO2001025217A1 (en)	1999-10-01	2000-09-29	New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds

Publications (2)

Publication Number	Publication Date
PL357385A1 true PL357385A1 (pl)	2004-07-26
PL202680B1 PL202680B1 (pl)	2009-07-31

Family

ID=8239103

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL357385A PL202680B1 (pl)	1999-10-01	2000-09-29	Nowe pochodne pirymidyno-2,4,6-trionu, środek farmaceutyczny i zastosowanie tych pochodnych

Country Status (28)

Country	Link
US (1)	US6498252B1 (pl)
EP (1)	EP1226128B1 (pl)
JP (1)	JP3848160B2 (pl)
KR (1)	KR100459975B1 (pl)
CN (1)	CN1157382C (pl)
AR (1)	AR033651A1 (pl)
AT (1)	ATE289595T1 (pl)
AU (1)	AU768309B2 (pl)
BR (1)	BR0014678A (pl)
CA (1)	CA2385863C (pl)
CO (1)	CO5210860A1 (pl)
CZ (1)	CZ20021535A3 (pl)
DE (1)	DE60018301T2 (pl)
ES (1)	ES2235955T3 (pl)
HU (1)	HUP0202832A3 (pl)
IL (1)	IL148573A0 (pl)
MA (1)	MA26823A1 (pl)
MX (1)	MXPA02003192A (pl)
NO (1)	NO20021380D0 (pl)
NZ (1)	NZ517635A (pl)
PE (1)	PE20010659A1 (pl)
PL (1)	PL202680B1 (pl)
RU (1)	RU2248971C2 (pl)
TR (1)	TR200200858T2 (pl)
UY (1)	UY26362A1 (pl)
WO (1)	WO2001025217A1 (pl)
YU (1)	YU22102A (pl)
ZA (1)	ZA200201754B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716845B2 (en) *	2001-03-30	2004-04-06	Hoffmann-La Roche Inc.	Barbituric acid derivatives
AU2002346729A1 (en)	2001-12-20	2003-07-09	Bristol-Myers Squibb Company	Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
WO2004084903A1 (en) *	2003-03-27	2004-10-07	F. Hoffmann-La Roche Ag	Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis
WO2004084902A1 (en) *	2003-03-28	2004-10-07	F. Hoffmann-La Roche Ag	Use of a trioxopyrimidine for the treatment of chronic wounds
EP1737464B1 (en) *	2004-04-01	2008-07-23	F. Hoffmann-La Roche AG	Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases
AU2005230380B2 (en) *	2004-04-01	2010-09-23	Universite De Liege	Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones
EP1632489A1 (en) *	2004-08-24	2006-03-08	University of Liege	5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use.
RU2449994C1 (ru) *	2011-03-10	2012-05-10	Светлана Алексеевна Мещерякова	6-(4-бензилпиперазино)-1,3-диметилурацила дигидрохлорид, проявляющий биологическую активность
RU2598607C1 (ru) *	2015-07-16	2016-09-27	Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет" (Астраханский государственный университет)	Способ получения 5-гетарилметиленпиримидин-2,4,6-трионов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1246743B (de) *	1965-01-12	1967-08-10	Dresden Arzneimittel	Verfahren zur Herstellung von 5-Phenyl-5-piperidinobarbitursaeuren
US4595700A (en)	1984-12-21	1986-06-17	G. D. Searle & Co.	Thiol based collagenase inhibitors
GB8726714D0 (en)	1987-11-14	1987-12-16	Beecham Group Plc	Compounds
GB8827305D0 (en)	1988-11-23	1988-12-29	British Bio Technology	Compounds
US5239078A (en)	1990-11-21	1993-08-24	Glycomed Incorporated	Matrix metalloprotease inhibitors
ES2069833T3 (es)	1990-12-03	1995-05-16	Celltech Ltd	Derivados peptidilicos.
CA2058797A1 (en)	1991-02-01	1992-08-02	Michael John Broadhurst	Amino acid derivatives
US5789434A (en)	1994-11-15	1998-08-04	Bayer Corporation	Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
ES2233275T3 (es)	1995-12-08	2005-06-16	Agouron Pharmaceuticals, Inc.	Intermediarios que sirven para la preparacion de inhibidores de metaloproteinasas.
DE19548624A1 (de)	1995-12-23	1997-06-26	Boehringer Mannheim Gmbh	Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6350786B1 (en) *	1998-09-22	2002-02-26	Hoffmann-La Roche Inc.	Stable complexes of poorly soluble compounds in ionic polymers

2000
- 2000-09-27 AR ARP000105063A patent/AR033651A1/es not_active Application Discontinuation
- 2000-09-27 PE PE2000001013A patent/PE20010659A1/es not_active Application Discontinuation
- 2000-09-27 CO CO00073355A patent/CO5210860A1/es not_active Application Discontinuation
- 2000-09-29 TR TR2002/00858T patent/TR200200858T2/xx unknown
- 2000-09-29 CA CA002385863A patent/CA2385863C/en not_active Expired - Fee Related
- 2000-09-29 CZ CZ20021535A patent/CZ20021535A3/cs unknown
- 2000-09-29 YU YU22102A patent/YU22102A/sh unknown
- 2000-09-29 DE DE60018301T patent/DE60018301T2/de not_active Expired - Lifetime
- 2000-09-29 AU AU77849/00A patent/AU768309B2/en not_active Ceased
- 2000-09-29 EP EP00967823A patent/EP1226128B1/en not_active Expired - Lifetime
- 2000-09-29 JP JP2001528163A patent/JP3848160B2/ja not_active Expired - Fee Related
- 2000-09-29 AT AT00967823T patent/ATE289595T1/de not_active IP Right Cessation
- 2000-09-29 WO PCT/EP2000/009535 patent/WO2001025217A1/en not_active Ceased
- 2000-09-29 UY UY26362A patent/UY26362A1/es not_active Application Discontinuation
- 2000-09-29 BR BR0014678-1A patent/BR0014678A/pt not_active Application Discontinuation
- 2000-09-29 NZ NZ517635A patent/NZ517635A/en unknown
- 2000-09-29 HU HU0202832A patent/HUP0202832A3/hu unknown
- 2000-09-29 MX MXPA02003192A patent/MXPA02003192A/es active IP Right Grant
- 2000-09-29 US US09/675,935 patent/US6498252B1/en not_active Expired - Fee Related
- 2000-09-29 IL IL14857300A patent/IL148573A0/xx unknown
- 2000-09-29 KR KR10-2002-7003979A patent/KR100459975B1/ko not_active Expired - Fee Related
- 2000-09-29 PL PL357385A patent/PL202680B1/pl not_active IP Right Cessation
- 2000-09-29 CN CNB00813006XA patent/CN1157382C/zh not_active Expired - Fee Related
- 2000-09-29 RU RU2002110106/04A patent/RU2248971C2/ru not_active IP Right Cessation
- 2000-09-29 ES ES00967823T patent/ES2235955T3/es not_active Expired - Lifetime
2002
- 2002-03-01 ZA ZA200201754A patent/ZA200201754B/en unknown
- 2002-03-20 NO NO20021380A patent/NO20021380D0/no not_active Application Discontinuation
- 2002-04-01 MA MA26578A patent/MA26823A1/fr unknown

Also Published As

Publication number	Publication date
CO5210860A1 (es)	2002-10-30
CN1374954A (zh)	2002-10-16
WO2001025217A1 (en)	2001-04-12
HK1050198A1 (en)	2003-06-13
MA26823A1 (fr)	2004-12-20
MXPA02003192A (es)	2002-09-30
PL202680B1 (pl)	2009-07-31
YU22102A (sh)	2004-11-25
AU768309B2 (en)	2003-12-04
NZ517635A (en)	2003-11-28
IL148573A0 (en)	2002-09-12
HUP0202832A2 (hu)	2003-02-28
HUP0202832A3 (en)	2003-03-28
US6498252B1 (en)	2002-12-24
CZ20021535A3 (cs)	2002-11-13
JP2003511376A (ja)	2003-03-25
ATE289595T1 (de)	2005-03-15
BR0014678A (pt)	2002-07-23
NO20021380L (no)	2002-03-20
NO20021380D0 (no)	2002-03-20
TR200200858T2 (tr)	2002-07-22
DE60018301T2 (de)	2006-04-06
PE20010659A1 (es)	2001-06-20
CA2385863A1 (en)	2001-04-12
UY26362A1 (es)	2001-04-30
CA2385863C (en)	2009-04-14
EP1226128A1 (en)	2002-07-31
ZA200201754B (en)	2003-06-02
JP3848160B2 (ja)	2006-11-22
KR100459975B1 (ko)	2004-12-03
DE60018301D1 (de)	2005-03-31
ES2235955T3 (es)	2005-07-16
CN1157382C (zh)	2004-07-14
AR033651A1 (es)	2004-01-07
AU7784900A (en)	2001-05-10
RU2248971C2 (ru)	2005-03-27
EP1226128B1 (en)	2005-02-23
KR20020039356A (ko)	2002-05-25

Similar Documents

Publication	Publication Date	Title
HUP0204226A3 (en)	2003-07-28	Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0105114A3 (en)	2002-09-30	Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
HUP0203542A3 (en)	2003-07-28	3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP0201832A3 (en)	2003-02-28	Quinazoline derivatives, pharmaceutical compositions containing these compounds, and processes for preparing them
HUP0201122A3 (en)	2003-11-28	Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
ZA985406B (en)	1999-12-22	Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds.
HUP0203766A3 (en)	2008-01-28	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0203142A3 (en)	2003-03-28	Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
GB9911053D0 (en)	1999-07-14	4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
HUP0204170A3 (en)	2005-03-29	5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
HUP9901820A3 (en)	2001-10-29	4-amino pyrimidine derivatives, medicaments containing these compounds, their use and process for their production
HUP0104964A3 (en)	2003-02-28	Quinazoline derivatives as angiogenesis inhibitors, process for their preparation and medicaments containing the compounds
HUP0202795A3 (en)	2003-03-28	Pyrimidine and pyrazine derivatives, pharmaceutical compositions containing them and their use
IL145647A0 (en)	2002-06-30	1,4-benzothiazepine -1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
HUP0000851A3 (en)	2002-04-29	Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0000748A3 (en)	2003-12-29	4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203294A3 (en)	2003-03-28	Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0002893A3 (en)	2001-07-30	Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203136A3 (en)	2003-03-28	Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0202501A3 (en)	2003-02-28	Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
HUP0203183A3 (en)	2006-02-28	Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
IL138969A0 (en)	2001-11-25	Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL148870A (en)	2007-05-15	2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP0203385A3 (en)	2003-07-28	Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL143577A0 (en)	2002-04-21	Piperazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date	Code	Title	Description
2010-11-30	LAPS	Decisions on the lapse of the protection rights	Effective date: 20090929